A recent Cloudera report highlights significant challenges enterprises face in implementing AI projects, with 95% having delayed or canceled initiatives due to infrastructure limitations. The survey findings, from over 1,500 IT architects, indicate a widespread need for overhauling legacy data architectures to support scalable and secure AI across hybrid environments. This shift, termed "The Great AI Re-Architecture," underscores the increasing complexity of data governance and the ongoing transition towards hybrid data infrastructures. As organizations navigate these challenges, the emphasis is on building flexible systems that can efficiently integrate AI, ensuring data management and governance are equipped to handle modern demands.

Elsewhere in the market, Wangsu Science & TechnologyLtd (SZSE:300017) was a standout up 20% and ending the day at CN¥17.33. At the same time, Trend Micro (TSE:4704) softened, down 14.6% to end the day at ¥5,851. This week, Trend Micro revised its annual earnings guidance downward due to rising cloud-related expenses impacting operating income projections.

Best Cloud AI Stocks

• Oracle (NYSE:ORCL) settled at $156.22 up 1.9%. Oracle has formed a strategic partnership with Amazon Web Services, announced yesterday, to enhance customer migration to Oracle AI Database@AWS.
• Microsoft (NasdaqGS:MSFT) ended the day at $496.88 up 0.9%. This week, Microsoft announced expanded AI collaborations with S&P Global for seamless data integration into Microsoft 365 and ZoomInfo for sales experiences in Copilot Studio.
• Alphabet (NasdaqGS:GOOGL) closed at $346.36 up 0.8%. ASUS announced a collaboration with Google on 2 days ago, offering customers expanded cloud AI services with select laptop purchases at no extra cost.

Taking Advantage

• Dive into all 156 of the Cloud AI Stocks we have identified, like SailPoint, Open Text and NICE, right here.
• Searching for a Fresh Perspective? The end of cancer? These 33 emerging AI stocks are developing tech that will allow early identification of life changing diseases like cancer and Alzheimer's.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Sources: